Format

Send to

Choose Destination
See comment in PubMed Commons below
F1000Res. 2013 Apr 8;2:105. doi: 10.12688/f1000research.2-105.v1.

Advances in systemic therapy for advanced pancreatobiliary malignancies.

Author information

1
Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
2
The Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.

Abstract

Pancreatobiliary malignancies are relatively uncommon and the overall prognosis is poor. Treatment options for advanced disease are limited to systemic therapy for metastatic disease and a combination of systemic therapy and radiation therapy for locally advanced but unresectable tumors. There have been significant advances in the treatment of pancreatobiliary cancers in recent years but the prognosis for patient survival remains disappointingly poor. We review the current treatment options for locally advanced pancreatobiliary malignancies and highlight recent advances in systemic therapy, including novel approaches using targeted treatments.

PMID:
24358840
DOI:
10.12688/f1000research.2-105.v1
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for F1000 Research Ltd
    Loading ...
    Support Center